Host: Paul Raeburn
Guest: Prof. John Kastelein, Chief Scientific Officer, NewAmsterdam Pharma
This special report from the 2008 American College of Cardiology conference features highlights of several leading research studies unveiled at the meeting, including the first release of scientific details of the ENHANCE trial. Several leading cardiologists, including ENHANCE trial principal investigator, Dr. John Kastelein, give host Paul Raeburn their candid reactions to the ENHANCE findings.
